Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    FibroBiologics Inc. Commo...

    NASDAQ: FBLG · Real-Time Price · USD
    0.94
    0.09 (10.04%)
    At close: Jun 06, 2025, 3:59 PM
    0.97
    3.53%
    After-hours: Jun 06, 2025, 05:54 PM EDT

    FibroBiologics Common Stock Statistics

    Share Statistics

    FibroBiologics Common Stock has 38.26M shares outstanding. The number of shares has increased by 11.28% in one year.

    Shares Outstanding

    n/a
    		 38.26M

    Shares Change (YoY)

    n/a
    		 11.28%

    Shares Change (QoQ)

    n/a
    		 5.05%

    Owned by Institutions (%)

    n/a
    		 16.01%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 4,934

    FTD / Avg. Volume

    n/a
    		 2.39%

    Short Selling Information

    The latest short interest is 1.57M, so 4.1% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.57M

    Short % of Shares Out

    n/a
    		 4.1%

    Short % of Float

    n/a
    		 4.86%

    Short Ratio (days to cover)

    n/a
    		 8.26

    Valuation Ratios

    The PE ratio is -5.89 and the forward PE ratio is -1.81. FibroBiologics Common Stock's PEG ratio is 0.14.

    PE Ratio

    n/a
    		 -5.89

    Forward PE

    n/a
    		 -1.81

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 24.04

    P/FCF Ratio

    n/a
    		 -5.44

    PEG Ratio

    n/a
    		 0.14
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for FibroBiologics Common Stock.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.12, with a Debt / Equity ratio of 3.86.

    Current Ratio

    n/a
    		 1.12

    Quick Ratio

    n/a
    		 1.12

    Debt / Equity

    n/a
    		 3.86

    Debt / EBITDA

    n/a
    		 -0.77

    Debt / FCF

    n/a
    		 -0.87

    Interest Coverage

    n/a
    		 -686.85

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-858,538.46

    Employee Count

    n/a
    		 13

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -91.95% in the last 52 weeks. The beta is -0.78, so FibroBiologics Common Stock's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.78

    52-Week Price Change

    n/a
    		 -91.95%

    50-Day Moving Average

    n/a
    		 0.95

    200-Day Moving Average

    n/a
    		 1.87

    Relative Strength Index (RSI)

    n/a
    		 47.4

    Average Volume (20 Days)

    n/a
    		 206,698

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -13.74M

    Net Income

    n/a
    		 -11.16M

    EBITDA

    n/a
    		 -13.74M

    EBIT

    n/a
    		 -11.18M

    Earnings Per Share (EPS)

    n/a
    		 -0.34
    Full Income Statement

    Balance Sheet

    The company has 13.98M in cash and 10.55M in debt, giving a net cash position of 3.43M.

    Cash & Cash Equivalents

    n/a
    		 13.98M

    Total Debt

    n/a
    		 10.55M

    Net Cash

    n/a
    		 3.43M

    Retained Earnings

    n/a
    		 -35.52M

    Total Assets

    n/a
    		 11.43M

    Working Capital

    n/a
    		 1.12M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -11.9M and capital expenditures -184K, giving a free cash flow of -12.09M.

    Operating Cash Flow

    n/a
    		 -11.9M

    Capital Expenditures

    n/a
    		 -184K

    Free Cash Flow

    n/a
    		 -12.09M

    FCF Per Share

    n/a
    		 -0.37
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    FBLG does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for FBLG is $12, which is 1345.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $12

    Price Target Difference

    n/a
    		 1345.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -4.97

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist